Quantitative pharmacogenetics of cyclophosphamide in patients with hematological malignancies.

被引:0
|
作者
Hassan, M [1 ]
Xie, HJ [1 ]
Stahle, L [1 ]
Hassan, Z [1 ]
Kimby, E [1 ]
机构
[1] Karolinska Inst, TDM Lab, Dept Clin Pharmacol, Stockholm, Sweden
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
4604
引用
收藏
页码:235B / 235B
页数:1
相关论文
共 50 条
  • [1] Pharmacogenetics of cyclophosphamide in patients with hematological malignancies
    Xie, HJ
    Griskevicius, L
    Ståhle, L
    Hassan, Z
    Yasar, Ü
    Rane, A
    Broberg, U
    Kimby, E
    Hassan, M
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2006, 27 (01) : 54 - 61
  • [2] Thiotepa and cyclophosphamide as conditioning regimen for high-risk patients with hematological malignancies.
    Fabre, E
    Boiron, JM
    Pigneux, A
    Dazey, B
    Agape, P
    Cony-Makhoul, P
    Lacombe, F
    Bouzgarrou, R
    Reiffers, J
    [J]. BONE MARROW TRANSPLANTATION, 1998, 21 : S97 - S97
  • [3] Liver patology in patients with hematological malignancies.
    Domnikova, Natalia P.
    Teterina, Natalia V.
    [J]. BLOOD, 2006, 108 (11) : 186B - 186B
  • [4] A new biomarker in hematological malignancies.
    Borgovan, Theo
    [J]. CANCER RESEARCH, 2021, 81 (13)
  • [5] Levofloxacin as antibacterial prophylaxis in neutropenic patients with hematological malignancies.
    Timmers, GJ
    Simoons-Smit, IM
    van Winkelhoff, AJ
    Dijstelbloem, Y
    Touw, D
    Vandenbroucke-Grauls, CM
    Huijgens, PC
    [J]. BLOOD, 2000, 96 (11) : 344B - 344B
  • [6] SELINEXOR PHARMACOKINETICS (PK) IN PATIENTS WITH ADVANCED HEMATOLOGICAL MALIGNANCIES.
    Bader, J.
    Porter, K.
    Shah, J.
    Shacham, S.
    Xu, H.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 : S52 - S52
  • [7] Outcomes after nonablative cyclophosphamide/fludarabine conditioning and related/unrelated allotransplantation for hematological malignancies.
    Nelson, Robert
    Robertson, Michael
    Cripe, Larry
    Hromas, Robert
    Yu, Menggang
    Schwartz, Jennifer
    Vance, Gail
    Dlouhy, Stephen
    Robertson, Kent
    Haut, Paul
    Cornetta, Kenneth
    Abonour, Rafat
    [J]. CLINICAL IMMUNOLOGY, 2006, 119 : S160 - S160
  • [8] Relationship between spiritual health and depression of patients with hematological malignancies.
    Chong, Sang Ok
    [J]. ONCOLOGY NURSING FORUM, 2007, 34 (02) : 498 - 499
  • [9] The length of survival (LOS) in hospice of cancer patients with hematological malignancies.
    Younis, TH
    Milch, RA
    Abul-Khoudoud, NR
    Lawrence, DD
    Mirand, AL
    Levine, EG
    [J]. BLOOD, 2003, 102 (11) : 508B - 508B
  • [10] Expression of testicular genes in hematological malignancies.
    Lim, SH
    Austin, S
    Owen-Jones, E
    Robinson, L
    [J]. BLOOD, 1998, 92 (10) : 246B - 247B